It is a
lysosomal protein, encoded in humans by the GALCgene.[1][2] Mutations in this gene have been associated with
Krabbe disease, also known as galactosylceramide lipidosis.[1]
Formichi P, Radi E, Battisti C, et al. (2007). "Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients". J. Cell. Physiol. 212 (3): 737–743.
doi:
10.1002/jcp.21070.
PMID17458901.
S2CID39182882.
Beier UH, Görögh T (2005). "Implications of galactocerebrosidase and galactosylcerebroside metabolism in cancer cells". Int. J. Cancer. 115 (1): 6–10.
doi:
10.1002/ijc.20851.
PMID15657896.
S2CID1013550.
Sakai N, Fukushima H, Inui K, et al. (1998). "Human galactocerebrosidase gene: promoter analysis of the 5'-flanking region and structural organization". Biochim. Biophys. Acta. 1395 (1): 62–67.
doi:
10.1016/S0167-4781(97)00140-1.
PMID9434153.
Harzer K, Knoblich R, Rolfs A, et al. (2002). "Residual galactosylsphingosine (psychosine) beta-galactosidase activities and associated GALC mutations in late and very late onset Krabbe disease". Clin. Chim. Acta. 317 (1–2): 77–84.
doi:
10.1016/S0009-8981(01)00791-4.
PMID11814461.
Flachsbart F, Franke A, Kleindorp R, et al. (2010). "Investigation of genetic susceptibility factors for human longevity - a targeted nonsynonymous SNP study". Mutat. Res. 694 (1–2): 13–19.
doi:
10.1016/j.mrfmmm.2010.08.006.
PMID20800603.